Analyst consensus rating
Allarity Therapeutics Analyst Rating: none
Direct answer
Allarity Therapeutics's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.00.
Forecast evidence checked October 27, 2026.
Get free Allarity Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.92
- Average price target
- $11.00
- High price target
- $11.00
- Low price target
- $11.00
- Low target gap
- +1,095.7%
- Target upside
- +1,095.7%
- High target gap
- +1,095.7%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Allarity Therapeutics?
Allarity Therapeutics has a verified none consensus. The same dataset has an average price target of $11.00.
How far are Allarity Therapeutics's low and high targets from the recorded price?
The low target implies +1,095.7%, while the high target implies +1,095.7%.
How many analysts are included in Allarity Therapeutics's consensus?
The verified consensus includes 1 analysts.
How is Allarity Therapeutics's target upside or downside calculated?
The average target of $11.00 is divided by the recorded price of $0.92, then one is subtracted to produce +1,095.7%. This does not guarantee a future return.
When was Allarity Therapeutics's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.